KA87.0

ICD-11 MMS 2026-01

Neonatal hyperbilirubinaemia due to swallowed maternal blood

Description

A condition characterised as an increased level of bilirubin above 85 umol/l (5 mg/dL) which manifests as yellowing of the eyes, skin, and other tissues of a newborn due consumption by the newborn of blood from the mother.

Coding note from above levels

Conditions arising in the perinatal period, even though death or morbidity occurs later, should, as far as possible, be coded to chapter 19, which takes precedence over chapters containing codes for diseases by their anatomical site. For children less than 28 days old, assume that a reported condition developed in the perinatal period, unless the duration is stated and the onset was after the first completed week of life.

Index terms

  • Neonatal hyperbilirubinaemia due to swallowed maternal blood

Exclusions from above levels

  • KA84.0 – jaundice due to isoimmunization
  • 3A10 – Hereditary haemolytic anaemia
  • 5C58.00 – Crigler-Najjar syndrome
Show allHide
  • 5C58.01 – Gilbert syndrome
  • 5C58.02 – Dubin-Johnson syndrome
  • LB20.22 – Congenital stenosis or stricture of bile ducts
  • 01 – Certain infectious or parasitic diseases - acquired after birth
  • 02 – Neoplasms
  • 05 – Endocrine, nutritional or metabolic diseases
  • 08 – Certain congenital diseases of the nervous system
  • 20 – Congenital malformations, deformations and chromosomal abnormalities
  • 22 – Injury, poisoning or certain other consequences of external causes
  • 4A01.03 – Transient hypogammaglobulinaemia of infancy
  • 9B71.3 – Retinopathy of prematurity
  • BC43 – congenital cardiomyopathy
  • DA93.0 – Paralytic ileus
  • EA50.Z – Pemphigus neonatorum
  • EH40.00 – Cradle cap
  • http://id.who.int/icd/entity/588616678 – Gastroenteritis or colitis of infectious origin
  • http://id.who.int/icd/entity/609214049 – Congenital gonococcal infection

Sibling codes

  • KA87.1 – Neonatal hyperbilirubinaemia due to enzymatic defect in bilirubin degradation
  • KA87.2 – Neonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugation
  • KA87.3 – Neonatal hyperbilirubinaemia due to total parenteral nutrition
  • KA87.4 – Neonatal hyperbilirubinaemia due to drugs or toxins transmitted from mother
  • KA87.5 – Neonatal hyperbilirubinaemia due to drugs or toxins given to newborn
  • KA87.6 – Neonatal hyperbilirubinaemia from other or unspecified hepatocellular damage
  • KA87.Y – Other specified neonatal hyperbilirubinaemia
  • KA87.Z – Neonatal hyperbilirubinaemia, unspecified

Foundation entity

Neonatal hyperbilirubinaemia due to swallowed maternal blood – http://id.who.int/icd/entity/1857068994

Part of: KA87: Neonatal hyperbilirubinaemia › 19: Certain conditions originating in the perinatal period